Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn:
“Anne Chiang. Great work discussion new land scale for SCLC what is the gap?
We still have no ideal sequence of drugs. The Great news is that we have new molecules to fit large number of different patients profiles.”
Other articles about SCLC on OncoDaily.
